Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome

NCT05617625 is registered in ClinicalTrials.gov with Guenther Koehne as lead sponsor.

NCT NCT05617625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome
Lead sponsor
Guenther Koehne
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
January 31, 2034
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, graft-versus-host-disease, myelodysplastic syndromes